Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate added to mepivacaine for IANB in pulpitis
NCT04561921Unknown
- Sponsor
- Cairo University
- Start
- Oct 2020
- Primary completion
- Oct 2021
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of magnesium sulfate in irreversible pulpitis, sponsored by Cairo University. Primary endpoint: Success of inferior alveolar nerve block at 15 minutes. Status: unknown.
02
Drugs
magnesium sulfate
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT04561921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04561921.